loading

Ionis Pharmaceuticals Inc (IONS) 最新ニュース

pulisher
02:37 AM

Ionis Pharmaceuticals stock hits 52-week high at 64.89 USD By Investing.com - Investing.com Nigeria

02:37 AM
pulisher
Sep 30, 2025

What analysts say about Ionis Pharmaceuticals Inc ISI stockDividend Stock Watch & High Return Wealth Plans - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

Alnylam and Ionis Pharmaceuticals are the leading companies - openPR.com

Sep 30, 2025
pulisher
Sep 30, 2025

Applying big data sentiment scoring on Ionis Pharmaceuticals Inc.2025 Historical Comparison & Risk Controlled Stock Pick Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Is Ionis Pharmaceuticals Inc. (ISI) stock in buy zone after pullbackWeekly Market Summary & Expert-Curated Trade Recommendations - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Why ETFs are accumulating Ionis Pharmaceuticals Inc. (ISI) stockPortfolio Gains Report & Comprehensive Market Scan Reports - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Investor Ratings Indicate Promising Upside Potential - DirectorsTalk Interviews

Sep 29, 2025
pulisher
Sep 29, 2025

Published on: 2025-09-29 03:15:49 - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

What drives Ionis Pharmaceuticals Inc stock priceVolume Weighted Average Price & Minimal Investment Profits - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Assenagon Asset Management S.A. Purchases New Position in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat

Sep 28, 2025
pulisher
Sep 28, 2025

Should you hold or exit Ionis Pharmaceuticals Inc. nowQuarterly Market Review & Real-Time Volume Trigger Notifications - newser.com

Sep 28, 2025
pulisher
Sep 28, 2025

Using fundamentals and technicals on Ionis Pharmaceuticals Inc.Trade Volume Report & Risk Controlled Daily Trade Plans - newser.com

Sep 28, 2025
pulisher
Sep 27, 2025

Is Ionis Pharmaceuticals Inc. (ISI) stock a fit for income portfoliosJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

Ionis Pharmaceuticals (IONS) Is Up 5.0% After Positive Phase III Results for Alexander Disease Therapy - Yahoo Finance

Sep 27, 2025
pulisher
Sep 26, 2025

IONS Upgraded by Goldman Sachs with a Significant Price Target I - GuruFocus

Sep 26, 2025
pulisher
Sep 26, 2025

Ionis Pharmaceuticals (NASDAQ:IONS) Rating Increased to Neutral at The Goldman Sachs Group - MarketBeat

Sep 26, 2025
pulisher
Sep 26, 2025

Leerink Partnrs Has Positive Outlook of IONS FY2025 Earnings - MarketBeat

Sep 26, 2025
pulisher
Sep 26, 2025

Goldman Sachs Upgrades Ionis Pharmaceuticals to Neutral From Sell, Adjusts PT to $65 From $45 - MarketScreener

Sep 26, 2025
pulisher
Sep 24, 2025

Ionis chalks up rare disease win with zilganersen - The Pharma Letter

Sep 24, 2025
pulisher
Sep 24, 2025

Is Ionis Pharmaceuticals Inc. meeting your algorithmic filter criteria2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com

Sep 24, 2025
pulisher
Sep 24, 2025

Morgan Stanley Raises Ionis Pharmaceuticals (IONS) Price Target to $86 | IONS Stock News - GuruFocus

Sep 24, 2025
pulisher
Sep 24, 2025

Ionis Pharmaceuticals stock price target raised to $68 by Leerink Partners - Investing.com UK

Sep 24, 2025
pulisher
Sep 23, 2025

IONS' Rare Neurological Disease Drug Meets Late-Stage Study Goal - sharewise.com

Sep 23, 2025
pulisher
Sep 23, 2025

Hereditary Angioedema Market Outlook 2034 – Clinical Trials, Market Size, Medication, Prevalence, Companies by DelveInsight - Barchart.com

Sep 23, 2025
pulisher
Sep 23, 2025

Ionis Pharmaceuticals Larger Than S&P 500 Component Align Technology - Nasdaq

Sep 23, 2025
pulisher
Sep 23, 2025

Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen - Biogen

Sep 23, 2025
pulisher
Sep 23, 2025

A Look at Ionis Pharmaceuticals’s Valuation as Zilganersen Delivers Breakthrough Results in Alexander Disease - Sahm

Sep 23, 2025
pulisher
Sep 23, 2025

Biotech Stocks Rally. 3 Favorite Plays From the Charts. - Barron's

Sep 23, 2025
pulisher
Sep 23, 2025

Ionis Pharma’s Drug for Rare Disease With No Approved Therapies Meets Goals of Pivotal Study - MedCity News

Sep 23, 2025
pulisher
Sep 23, 2025

Barclays Maintains Overweight Rating on IONS, Raises Price Targe - GuruFocus

Sep 23, 2025
pulisher
Sep 23, 2025

Ionis Pharma Stock Rises After Multiple Price Target Hikes On Heels Of Positive Study Results In Alexander Disease - Stocktwits

Sep 23, 2025
pulisher
Sep 23, 2025

Guggenheim Raises Ionis Pharmaceuticals (IONS) Price Target to $92 | IONS Stock News - GuruFocus

Sep 23, 2025
pulisher
Sep 23, 2025

Ionis Pharmaceuticals (IONS): Analyst Rating Update and Target P - GuruFocus

Sep 23, 2025
pulisher
Sep 23, 2025

Guggenheim Forecasts Strong Price Appreciation for Ionis Pharmaceuticals (NASDAQ:IONS) Stock - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Raised to $83.00 at Bank of America - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Ionis Pharmaceuticals (NASDAQ:IONS) Receives "Buy" Rating from HC Wainwright - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Ionis Heads to FDA as Antisense Therapy Aces Pivotal Study in Rare Neurological Disease - BioSpace

Sep 23, 2025
pulisher
Sep 23, 2025

IONS: HC Wainwright Reiterates Buy Rating with $95 Target | IONS Stock News - GuruFocus

Sep 23, 2025
pulisher
Sep 23, 2025

Ionis reports positive results for Alexander disease drug zilganersen By Investing.com - Investing.com Nigeria

Sep 23, 2025
pulisher
Sep 23, 2025

Ionis announces positive topline results from pivotal study of zilganersen in Alexander disease - BioSpace

Sep 23, 2025
pulisher
Sep 22, 2025

Ionis Pharmaceuticals, Inc. $IONS Shares Sold by Sovran Advisors LLC - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Ionis Targets Ultra-Rare Disease Market With Zilganersen - insights.citeline.com

Sep 22, 2025
pulisher
Sep 22, 2025

Ionis reports positive results for Alexander disease drug zilganersen - Investing.com India

Sep 22, 2025
pulisher
Sep 22, 2025

Ionis says RNA drug for rare brain disorder succeeded pivotal trial, plans to ask for FDA approval - Endpoints News

Sep 22, 2025
pulisher
Sep 22, 2025

Ionis stock surges after positive results from Alexander disease drug By Investing.com - Investing.com Canada

Sep 22, 2025
pulisher
Sep 22, 2025

Ionis reports promising data from study of Alexander disease therapy - Seeking Alpha

Sep 22, 2025
pulisher
Sep 22, 2025

Ionis Pharmaceuticals Reveals 'Unprecedented Results' From Rare Neurological Disease Trial - Benzinga

Sep 22, 2025
pulisher
Sep 22, 2025

Hereditary Angioedema Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight - openPR.com

Sep 22, 2025
pulisher
Sep 22, 2025

Ionis Pharmaceuticals (IONS) Reveals Promising Results for Zilga - GuruFocus

Sep 22, 2025
pulisher
Sep 22, 2025

Ionis Pharma Reports Positive Topline Results From Pivotal Study Of Zilganersen In Alexander Disease - Nasdaq

Sep 22, 2025
pulisher
Sep 22, 2025

Ionis' brain disorder drug shows promise in clinical trial - TradingView

Sep 22, 2025
pulisher
Sep 22, 2025

Ionis and Sobi’s Tryngolza gains approval in EU for FCS treatment - Yahoo Finance

Sep 22, 2025
pulisher
Sep 22, 2025

Wedmont Private Capital Acquires New Shares in Ionis Pharmaceuticals, Inc. $IONS - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

TRYNGOLZA® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS) - BioSpace

Sep 22, 2025
pulisher
Sep 21, 2025

Will FDA Breakthrough Therapy Status for ION582 Redefine Ionis Pharmaceuticals' (IONS) Rare Disease Strategy? - Sahm

Sep 21, 2025
pulisher
Sep 21, 2025

About UsGreat American Insurance GroupSpecialty Property & Casualty Insurance - FinancialContent

Sep 21, 2025
pulisher
Sep 21, 2025

Stop Loss: Does Ionis Pharmaceuticals Inc stock have upside surprise potential - خودرو بانک

Sep 21, 2025
pulisher
Sep 21, 2025

Levels Update: What are Ionis Pharmaceuticals Incs earnings expectationsEarnings Overview Summary & Accurate Buy Signal Alerts - خودرو بانک

Sep 21, 2025
pulisher
Sep 20, 2025

Risk Off: Will Ionis Pharmaceuticals Inc stock recover after earningsJuly 2025 Opening Moves & Free Fast Entry Momentum Trade Alerts - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Insider Selling: Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells 1,700 Shares of Stock - MarketBeat

Sep 20, 2025
$36.34
price up icon 2.98%
$86.64
price up icon 2.16%
$31.66
price up icon 3.25%
$101.97
price up icon 3.39%
$147.45
price up icon 2.53%
biotechnology ONC
$342.31
price up icon 0.47%
大文字化:     |  ボリューム (24 時間):